"I expect XOMA 052, when administered to patients with Type 2 diabetes, to provide an effective inhibition of the IL-1 beta cytokine released by insulin producing islet cells. This inhibition may substantially block the progression of the disease."
XOMA Ltd. today announced the initiation of Phase I clinical testing of product candidate XOMA 052, a potent monoclonal antibody targeting Interleukin-1 beta , in patients with Type 2 diabetes.
Category: Health News
Created: 7/17/2007
Last Editorial Review: 7/17/2007
Category: Health News
Created: 7/18/2007 2:00:00 AM
Last Editorial Review: 7/18/2007
Starting Wednesday, Aug. 8, an educational program, Do Well, Be Well with Diabetes will be held at the Agricultural Building, 316 Spring Street, Columbus from 11:30 a.m. to 1 p.m. The 5-week series will be held ...
Main Category: Diabetes News Article Date: 19 Jul 2007 - 2:00 PDT newsletters 1. Review Finds Older Diabetes Drugs Have Similar or Superior Effects to Newer, Pricier Medications A review of published literature ...
SPRINGFIELD – The Illinois Department of Public Health this week announced a $20,000 fine against Helia Healthcare of Urbana for an incident involving a diabetic resident.
Pumpkin extract may replace or reduce daily injections for type 1 diabetics, new research suggests.
HEART BUTTE - Robert James Tail Feathers, 60, of Heart Butte, an Army veteran and ranch hand, died of complications from diabetes Thursday in .
Bad enough by itself, sleep apnea can lead to worse things -- such as serious car wrecks, heart disease, diabetes, and pregnancy complications.